Obstetrics & Gynecology Doctors in Milford, MI Accepting Medicare

1 Obstetrics & Gynecology doctors found. Showing 1 - 1

Dr. Kiran Balchandani, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1181 N Milford Rd, Suite 100, Milford, MI 48381 Phone: 248-685-0444    Fax: 248-684-0900

News Archive

ESMO Consortium Study advocates for equal access to quality cancer treatment across Asia

The European Society for Medical Oncology opened its 3rd ESMO Asia Congress today, once again in Singapore, attracting close to 3000 regional and international cancer doctors with leading researchers and experts to promote advances in science, diagnosis, treatment, and best practices for cancer patients in Asia.

New co-branded Medicare Part D prescription drug plan from Humana and Walmart

Today, Humana Inc. announced an innovative Medicare Part D prescription drug plan, co-branded with Wal-Mart Stores, Inc., that can provide significant savings on monthly plan premiums and prescription medicine copayments and cost-shares for Medicare beneficiaries, including seniors and people with disabilities.

Novartis purchases majority interest in Alcon from Nestlé for $28.3 billion

Novartis AG and Nestlé S.A. announced today that they have completed the purchase and sale of approximately 156 million shares of Alcon, Inc. for US$28.3 billion in cash.

Evidence of SARS-CoV-2 spreading in an airplane toilet

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease (COVID-19), is still actively spreading like wildfire, with nearly 300,000 new infections reported daily across the globe. Early on in the outbreak in China, scientists said that the virus could spread through respiratory droplets, when a person coughs, sneezes, or speaks.

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.

Read more Medical News

› Verified 7 days ago